01

JAAD Review Flags Kaposi Sarcoma as Emerging JAK Inhibitor Signal

A JAAD systematic review published online October 17, 2026 consolidates case reports of Kaposi sarcoma emerging during Janus kinase inhibitor therapy, framing it as a safety signal.